MedPath

Wyeth Lederle Vaccines

🇧🇪Belgium
Ownership
-
Employees
-
Market Cap
-
Website

A Study of GENEVAX-HIV, a Possible Vaccine

Phase 1
Completed
Conditions
HIV Infections
HIV Seronegativity
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Wyeth-Lederle Vaccines
Registration Number
NCT00002232
Locations
🇺🇸

Walter Reed Army Institute of Research, Washington, District of Columbia, United States

Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers

Phase 1
Completed
Conditions
HIV Seronegativity
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Wyeth-Lederle Vaccines
Registration Number
NCT00002231
Locations
🇺🇸

Univ of Pennsylvania Med Ctr, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath